Details of the Drug Reposition

General Information of This Drug (ID: DMUARWH)

Drug Name
CD19 CAR T Cells   DMUARWH
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Large cell lymphoma DISYZHCP 2A80.Z Phase 1/2 [1]
Diffuse large B-cell lymphoma DISSACK3 2A81 Phase 1/2 [1]
Chronic lymphocytic leukaemia DISEXWC3 2A82.0 Phase 1/2 [1]
Acute lymphoblastic leukaemia DIS87TGM 2A85 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01475058) CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant